Cyclodextrin's Effect on Permeability and Partition of Nortriptyline Hydrochloride
- PMID: 37513934
- PMCID: PMC10386514
- DOI: 10.3390/ph16071022
Cyclodextrin's Effect on Permeability and Partition of Nortriptyline Hydrochloride
Erratum in
-
Correction: Volkova et al. Cyclodextrin's Effect on Permeability and Partition of Nortriptyline Hydrochloride. Pharmaceuticals 2023, 16, 1022.Pharmaceuticals (Basel). 2023 Dec 29;17(1):57. doi: 10.3390/ph17010057. Pharmaceuticals (Basel). 2023. PMID: 38256964 Free PMC article.
Abstract
Cyclodextrin-based delivery systems have been intensively used to improve the bioavailability of drugs through the modification of their pharmaceutically relevant properties, such as solubility, distribution and membrane permeation. The present work aimed to disclose the influence of HP-β-CD and SBE-β-CD on the distribution and permeability of nortriptyline hydrochloride (NTT•HCl), a tricyclic antidepressant drug. To this end, the distribution coefficients in the 1-octanol/buffer and n-hexane/buffer model systems and the coefficients of permeability through the cellulose membrane and lipophilic PermeaPad barrier were determined at several cyclodextrin concentrations. The results demonstrated a dramatic decrease in both the distribution and the permeability coefficients as the cyclodextrin concentration rose, with the decrease being more pronounced in SBE-β-CD due to the charge-charge attraction and electrostatic interactions between NTT and SBE-β-CD. It is these interactions that were shown to be responsible for the greater value of the constant of NTT's association with SBE-β-CD than that with HP-β-CD. The findings of this study revealed similar trends in the 1-octanol/buffer 6.8 pH distribution and permeability through the PermeaPad barrier in the presence of CDs. These results were attributed to the determinative role of the distribution coefficient (serving as a descriptor) in permeation through the PermeaPad barrier modeling the lipophilic nature of biological barriers.
Keywords: HP-β-CD; PermeaPad barrier; SBE-β-CD; distribution; membrane permeability; nortriptyline hydrochloride.
Conflict of interest statement
The authors declare no conflict of interest.
Figures









References
-
- Avdeef A. Absorption and Drug Development: Solubility, Permeability and Charge State. John Wiley & Sons, Inc.; Hoboken, NJ, USA: 2012.
-
- Milcovich G., Lettieri S., Antunes F.E., Medronho B., Fonseca A.C., Coelho J.F.J., Marizza P., Perrone F., Farra R., Dapas B., et al. Recent advances in smart biotechnology: Hydrogels and nanocarriers for tailored bioactive molecules depot. Adv. Colloid Interface Sci. 2017;249:163–180. doi: 10.1016/j.cis.2017.05.009. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous